First-in-Human Dose Selection. Adaptive Trial Design. Autonomous Protocol Writing

Clinical trial operations is where biology meets logistics. The CureForge Clinical Trial Operations Institute is the federation’s research engine for that intersection. Ten specialized AI systems collaborate across first-in-human dose selection through allometric scaling and physiologically-based pharmacokinetic modeling, Bayesian adaptive trial design across the modern adaptive-trial classes, basket trial design for multi-indication single-target programs, umbrella trial design for single-indication multi-target programs, platform trial coordination, autonomous protocol writing, good-clinical-practice compliance, endpoint selection optimization, master-protocol coordination for rare-disease and n-of-few populations, and federated trial-data coordination across cross-jurisdictional cohorts. Outputs feed directly into the regulatory institute’s submission pipeline. Every protocol is reviewed by qualified clinical operations leadership.

Value proposition:

• First-in-human dose selection with full pharmacokinetic and pharmacodynamic modeling
• Bayesian adaptive, basket, umbrella, and platform trials as one engine
• Autonomous protocol writing with regulator-grade compliance review